Nyvepria
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nyvepria, covering 2020-06-10 to 2026-01-20. Get the full timeline:
Most recent: EMA Authorised: Nyvepria (pegfilgrastim) — Pfizer Europe MA EEIG
3 regulatory and trial events tracked for Nyvepria, covering 2020-06-10 to 2026-01-20. Get the full timeline:
Most recent: EMA Authorised: Nyvepria (pegfilgrastim) — Pfizer Europe MA EEIG